Resources

Providing the best advocacy resources for biosimilars.

The resource center is an information hub—great for gathering scientific, historical and policy-focused facts on safe and effective biosimilar medicines that have saved America’s patients and the U.S. healthcare system $36 billion since 2015.

The Biosimilars
Patient Resource Center

The Biosimilars Patient Resource Center is a convenient site for answers to your pressing questions about biosimilar medicines.

Whether you are a current or potential biosimilar or biologics patient, a caregiver, a medical professional, a policymaker, or if you just want to know more about biosimilars, the Biosimilars Patient Resource Center has information you can use.

Additional Resources

  • All
  • Backgrounder
  • Biosimilars Bulletin
  • Blog
  • Council Resource
  • Event
  • Handbook
  • Infographic
  • Issue Brief
  • Member Spotlight
  • Partner Resource
  • Policy Recommendation
  • Press Release
  • Report
  • Streamlining
  • Video
  • Whitepapers
Biosimilars Bulletin
Biosimilars Bulletin
Biosimilars Bulletin
Biosimilars Bulletin
Biosimilars Bulletin
Biosimilars Bulletin
Biosimilars Bulletin
People at GRx+Biosims
Biosimilar Bulletin June 2022, doctor advising patient.
Biosimilars patient resource center, bulletin
Doctor helping biosimilar patient
Biosimilar information
FDA-approved biosimilars
Biosimilar information
biosimilars news january 2021
biosimilars news december 2020
biosimilars facts
biosimilars news november 2020
biosimilars news october 2020
biosimilars help cancer patients
biosimilars bulletin september 2020
Biosimilars News May 2020
FDA-approved biosimilars
Biosimilars News August 2020
Biosimilars News July 2020
biosimilars benefit everyone
biosimilars in the pharmacy
Biosimilars news June 2020
Biosimilars News May 2020
biosimilars news april 2020
Bulletin March
twitter chat
biosimilars news january 2020
biosimilars in the united states
barriers to biosimilar adoption
are biosimilars safe
what is a biosimilar
interchangeable insulin
Biosimilars Council - AAM This Month - August - Pills Background
The Biosimilars Council - Female Pharmacist with Customer
The Biosimilars Council - Skyrocketing Drug Prices
The Biosimilars Council - Breaking Through on Biosimilars Whitepaper
Developing a Robust Biosimilars Market in the U.S.
Paving the Way for Biosimilars
The Biosimilars Council - GRxBiosims Event Banner
Medicare Part B Issue Brief
Biosimilars Medicare Part D

Stay Informed About Key Industry Issues